Evidence map›Paper›PMID 26492240›Full record

ReviewInternational journal of molecular sciences2015

High-Throughput Screening in Protein Engineering: Recent Advances and Future Perspectives.

Magdalena Wójcik, Aline Telzerow, Wim J Quax, Ykelien L Boersma

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. GGAssembler: Precise and economical design and synthesis of combinatorial mutation libraries.Protein science : a publication of the Protein Society · 2024
    Article
  4. Review
  5. Semirational engineering ofApplied and environmental microbiology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. A systematic analysis of the beta hairpin motif in the Protein Data Bank.Protein science : a publication of the Protein Society · 2021
    Article
  12. Article
  13. ACS synthetic biology · 2020
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. The Generation and Exploitation of Protein Mutability Landscapes for Enzyme Engineering.Chembiochem : a European journal of chemical biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Magdalena WójcikGroningen Research Institute of Pharmacy, Department of Pharmaceutical Biology, University of Groningen, A. Deusinglaan 1, 9717 AV Groningen, The Netherlands. m.wojcik@rug.nl.
Aline TelzerowGroningen Research Institute of Pharmacy, Department of Pharmaceutical Biology, University of Groningen, A. Deusinglaan 1, 9717 AV Groningen, The Netherlands. a.telzerow@student.rug.nl.
Wim J QuaxGroningen Research Institute of Pharmacy, Department of Pharmaceutical Biology, University of Groningen, A. Deusinglaan 1, 9717 AV Groningen, The Netherlands. w.j.quax@rug.nl.
Ykelien L BoersmaGroningen Research Institute of Pharmacy, Department of Pharmaceutical Biology, University of Groningen, A. Deusinglaan 1, 9717 AV Groningen, The Netherlands. y.l.boersma@rug.nl.
University of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last three decades, protein engineering has established itself as an important tool for the development of enzymes and (therapeutic) proteins with improved characteristics. New mutagenesis techniques and computational design tools have greatly aided in the advancement of protein engineering. Yet, one of the pivotal components to further advance protein engineering strategies is the high-throughput screening of variants. Compartmentalization is one of the key features allowing miniaturization and acceleration of screening. This review focuses on novel screening technologies applied in protein engineering, highlighting flow cytometry- and microfluidics-based platforms.

Indexed as

Flow CytometryHigh-Throughput Screening AssaysHumansMicrofluidicsProtein EngineeringFACS-based screening platformshigh-throughput screeningin vitro compartmentalizationmicrofluidics-based screening platformsprotein engineering

Identifiers

PMID26492240
PMCPMC4632782
OpenAlexW2121282106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.